Vestibular schwannoma

Last revised by Rohit Sharma on 25 Sep 2024

Vestibular schwannomas, also known as acoustic neuromas, are relatively common tumours that arise from the vestibulocochlear nerve (CN VIII) and represent ~80% of cerebellopontine angle (CPA) masses. Bilateral vestibular schwannomas are strongly suggestive of neurofibromatosis type 2 (NF2).

On imaging, they classically present as a solid nodular mass with an intracanalicular component that often results in widening of the porus acusticus. They usually show intense contrast enhancement and, when larger, cystic degeneration can be present. Haemorrhagic areas may also be seen, but calcification is typically not present.

Vestibular schwannomas are commonly known as acoustic neuromas, which is a misnomer. The term vestibular schwannoma is preferred as these tumours most frequently arise from the vestibular portion of the vestibulocochlear nerve and arise from Schwann cells 13. A mixture of the terms, acoustic schwannoma, may also be seen. 

Vestibular schwannomas account for ~8% 15 of all primary intracranial tumours 2 and 75-90% of CPA masses 1,2,8. The vast majority (95%) of solitary lesions are sporadic. Bilateral vestibular schwannomas are highly suggestive of neurofibromatosis type 2 (NF2), although bilateral tumours are encountered in the familial form of vestibular schwannomas in the absence of other stigmata of NF2 5.

Although they usually occur between the fourth to sixth decades of life, with a median age of 50 years 11, individuals with NF2 tend to present earlier, with a peak incidence around the third decade of life ref. Although rare, vestibular schwannomas may occur in children ref.

The typical presentation is with adult-onset sensorineural hearing loss or non-pulsatile tinnitus. In some patients, this goes unnoticed, and presentation is delayed until the lesion is much larger and presents with symptoms related to mass effect. Possibilities include cerebellar and brainstem symptoms (e.g. cranial nerve dysfunction, other than vestibulocochlear), or hydrocephalus due to effacement of the fourth ventricle. 

Vestibular schwannomas are benign tumours (WHO grade 1), which usually arise from the intracanalicular segment of the vestibular portion of the vestibulocochlear nerve (CN VIII) 2,4. They were classically described as originating near the transition zone between glial and Schwann cells but contemporary data suggests they can originate at any point along the nerve 8,16,17. In over 90% of cases, these tumours arise from the inferior division of the vestibular nerve 8. Less than 5% cases arise from the cochlear component of the vestibulocochlear nerve (CN VIII) 13.

They are well-circumscribed encapsulated masses that, unlike neuromas, arise from but are separate from nerve fibres 7, which they usually splay and displace rather than engulf.

They can display two types of growth patterns:

  • Antoni A

    • elongated cells with cytoplasmic processes arranged in fascicles 7

    • little stromal matrix

    • Verocay bodies: nuclear-free zones of processes lying between regions of nuclear palisading

  • Antoni B

    • loose meshwork of cells

    • less densely cellular

    • microcysts, foamy macrophages and myxoid change

Immunohistochemical staining is usually positive for S-100 protein 11.

  • most have an intracanalicular component, often widening the porus acusticus (trumpeted IAM sign) (up to 90%) 5

    • a small "CSF cap" typically remains, separating intracanalicular tumour from the cochlea; however, growth laterally through the cochlea (transmodiolar) or vestibule (transmacular) into the middle ear may occasionally occur

    • involvement of the IAC fundus is associated with decreased rates of hearing preservation

    • extracanalicular extension may result in an "ice cream cone" appearance, presumed to represent tumour growth inwards along a path of least resistance

  • a minority are purely extracanalicular, merely abutting the porus acusticus (~20%) 1,5

  • rarely, small tumours may be confined to the labyrinth (see intralabyrinthine schwannoma) 4

  • the location and extension can be classified according to the Koos grading scale

  • small tumours tend to be solid, but larger tumours commonly demonstrate cystic degeneration 2

  • may have haemorrhagic areas

  • typically without calcification

May show erosion and widening of the internal acoustic canal (IAC). The density of these tumours on non-contrast imaging is variable, and often they are hard to see, especially on account of beam hardening and streak artifact from the adjacent petrous temporal bone.

Contrast enhancement is present but can be underwhelming, especially in larger lesions with cystic components. Many cysts are loculations of CSF adjacent to a vestibular schwannoma, others represent cystic degeneration within schwannomas.

  • T1

    • slightly hypointense to the adjacent brain (63%) or isointense to it (37%) 2

    • may contain hypointense cystic areas

  • T2

    • heterogeneously hyperintense to adjacent brain 5

    • fluid intensity cystic areas

    • may have associated peritumoural arachnoid cysts 3

  • T1 C+ (Gd)

    • contrast enhancement is intense

    • however, heterogeneous in larger tumours

  • SWI

    • some shwannomas show areas of blooming due to the presence of intratumoural microhaemorrhages 22,23

Post-operational MRI

Linear enhancement may not indicate a tumour, but if there is nodular enhancement, suspect tumour recurrence (requires follow-up MRI).

There is variability in the rate of growth of vestibular schwannomas, and as such, the decision to treat requires consideration of the patient's age and co-morbidities. The options include 6 :

  • observation and follow-up

  • stereotactic radiosurgery

  • microsurgery: number of approaches are possible, including 8:

    • retrosigmoid (transmeatal) (suboccipital)

      • able to preserve hearing

      • can be used for large tumours

      • limited view of the internal auditory canal

      • has a greater chance of residual tumour (in the lateral aspect of internal auditory canal)

    • middle cranial fossa

      • best for small intracanalicular tumours

      • able to preserve hearing

    • translabyrinthine

      • careful skeletonisation of the facial nerve required (i.e. intraoperative facial nerve monitoring by needle electromyography with continuous stimulation)

      • loss of hearing guaranteed

Overall tumour recurrence is low, ranging between 1-9% 8.

The tumour was first described in 1777 by Dutch anatomist Eduard Sandifort (1742-1814) 12,14.

Schwann cells, and hence schwannomas, are named after the German physician and physiologist Theodor Schwann (1810–1882) 13.

The first case in which a patient survived surgical resection of a vestibular schwannoma was in 1894. The procedure was performed by British surgeon Sir Charles Balance 12.

Other regional schwannomas can be challenging to distinguish from vestibular schwannomas.

The differential for a small intracanalicular schwannoma includes:

  • vascular enhancement at the fundus of the internal auditory canal (such as the venous plexus around the nerve sheath or capillaries in the meninges) 18

  • normal enhancement Scarpa (vestibular) ganglion 19

  • low-flow vascular malformation (cavernous haemangioma) 20

Schwnnomas from other nerves, unless very large, are usually easily distinguished from vestibular schwannomas based on location.

More general differential considerations for a cerebellopontine angle mass includes:

In addition to general remarks about the size and location of the tumour, significant findings that influence surgical management include 8:

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.